about
Effects of holmium laser enucleation of the prostate on sexual function.Clinical Significance of Proliferative Inflammatory Atrophy in Negative Prostatic Biopsies.Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer.Serum Testosterone Levels in Prostate Cancer Patients Undergoing Luteinizing Hormone-Releasing Hormone Agonist Therapy.Prostatic-specific antigen density behavior according to multiparametric magnetic resonance imaging resultRe: Frank-Jan H. Drost, Daniel Osses, Daan Nieboer, et al. Prostate Magnetic Resonance Imaging, with or Without Magnetic Resonance Imaging-targeted Biopsy, and Systematic Biopsy for Detecting Prostate Cancer: A Cochrane Systematic Review and Meta-anHow to implement magnetic resonance imaging before prostate biopsy in clinical practice: nomograms for saving biopsiesEarly continence after radical prostatectomy: A systematic reviewRe: Lars Boesen, Nis Nørgaard, Vibeke Løgager, et al. Prebiopsy Biparametric Magnetic Resonance Imaging Combined with Prostate-specific Antigen Density in Detecting and Ruling out Gleason 7-10 Prostate Cancer in Biopsy-naïve Men. Eur Urol Oncol 2019The role of negative magnetic resonance imaging: can we safely avoid biopsy in P.I.-R.A.D.S. 2 as in P.I.-R.A.D.S. 1?Are targeted prostate biopsies ready to replace systematic prostate biopsies?In Search for risk predictors at the microscopic scenario of a negative biopsy. A systematic reviewWho Benefits from Multiparametric Magnetic Resonance Imaging After Suspicion of Prostate Cancer?Preoperative magnetic resonance imaging in predicting early continence recovery after robotic radical prostatectomyThe role of STAT3 protein as a prognostic factor in the clear cell renal carcinoma. Systematic review
P50
Q35227335-34679FFD-1BF5-427F-9ECC-AF895F6DB7C7Q38810572-516D1E62-F6DB-489C-AB3F-B85020DFED47Q42151262-74B5B2BD-76EE-4B20-9FDA-AEC4BC7D18FDQ49338884-B6426DE3-5E67-4797-A5BD-ACBE4995C32EQ89752255-1C5AA1E6-66A6-49A3-A3E3-86ED84AEDDA8Q89847908-32282AA4-ED67-450D-92F9-84C30BBCAAA9Q90046425-145F9228-32EE-4DE6-AA52-D80DDFCE2C22Q90670143-C8EC219A-1A1A-44B1-96E5-1C49232B8DD6Q90808584-3F49DEBF-67D6-48FC-B808-CCF280D81E7FQ90978286-5F64E21C-FFE4-4BC6-9E42-EBBBBB3940E5Q91076957-6B2BEB2E-56D8-4FFB-88C9-17AF808CDFC4Q92168607-999567B4-C42F-4A8D-8A53-7C17D9D2CA1EQ92616153-0AC88DC9-ABCC-437C-8AE9-1B4E958E9FADQ93013636-0A42D1B3-3B1B-4622-A946-65BA63209949Q93356879-43A0083C-E227-4885-89B0-50FDF5EDC757
P50
description
researcher
@en
name
Ana Celma
@en
type
label
Ana Celma
@en
prefLabel
Ana Celma
@en
P31
P496
0000-0002-3128-3811